SCHEMBL8796762

SCHEMBL8796762

[c]1nc2ccccc2n1-c1cc2ccccc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ AOC3 Q16853 2/20 0.36
▸ RAB9A P51151 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ ESR1 P03372 2/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7596618 0.71 HTT (0.49) FGFR1ALDH1A1TP53POLBHTT
SCHEMBL5610228 0.68 ALDH1A1 (0.41) PDGFRBFGFR1RAB9ANPC1KDM4E
SCHEMBL67806 0.68 HTT (0.42) FGFR1RAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL17861255 0.67 AHR (0.43) AOC3RAB9ANPC1KDM4EHSD17B10
SCHEMBL28409733 0.67 AOC3 (0.43) PDGFRBFGFR1KDRAOC3RAB9A
SCHEMBL5635166 0.67 CYP11B1 (0.40) FGFR1KDRAOC3RAB9ANPC1
SCHEMBL1409026 0.67 NPC1 (0.40) RAB9ANPC1KDM4ESMN1; SMN2HSD17B10
SCHEMBL547284 0.65 AOC3 (0.37) KDRAOC3RAB9ANPC1KDM4E
SCHEMBL30584610 0.65 AOC3 (0.44) FGFR1KDRAOC3RAB9ANPC1
SCHEMBL6947275 0.64 AOC3 (0.47) KDRAOC3RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772600-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 — — EP claimed
US-5616601-A 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation GD SEARLE & CO (US) 1997-04-01 — — US claimed
WO-1996003388-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 — — WO claimed
EP-0772600-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 — — EP disclosed
US-5616601-A 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation GD SEARLE & CO (US) 1997-04-01 — — US disclosed
WO-1996003388-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 — — WO disclosed
Send feedback